Table 1 Mean (standard deviation) values at baseline and 12 months after the Can Do treatment with relative difference (percentage of baseline) (mean, standard error of the mean) and P value for comparison (paired t-test) for self-efficacy [multiple sclerosis self-efficacy scale (MSSES)], impact on participation and autonomy [impact on participation and autonomy questionnaire (IPA)], HRQoL [multiple sclerosis quality of life-54 Items (MSQoL-54)], anxiety and depression [Hospital anxiety and depression scale (HADS)], and fatigue [modified fatigue impact scale-5 items (MFIS-5)] in the relapsing remitting group (N = 22); Δ, difference
Relapsing remitting group | Baseline | 12th month | % Δ | P |
|---|---|---|---|---|
MSSES function (N = 21) | 80.86 (15.00) | 79.58 (16.24) | −0.68 (3.00) | 0.708 |
MSSES control (N = 21) | 57.68 (19.29) | 64.02 (15.81) | +20.21 (7.83) | 0.012 |
IPA limitations (N = 22) | 2.40 (0.60) | 2.28 (0.60) | −0.53 (7.41) | 0.356 |
IPA problems (N = 20) | 1.97 (0.37) | 1.75 (0.51) | −8.38 (5.51) | 0.075 |
MSQoL-54 physical (N = 11) | 56.87 (11.93) | 59.85 (18.68) | +14.99 (7.09) | 0.032 |
MSQoL-54 mental (N = 17) | 55.98 (11.82) | 63.47 (14.12) | +17.38 (8.16) | 0.087 |
HADS anxiety (N = 22) | 7.23 (3.45) | 5.50 (3.16) | −25.89 (8.64) | 0.044 |
HADS depression (N = 22) | 5.59 (3.62) | 3.86 (3.23) | −29.76 (14.53) | 0.042 |
MFIS-5 (N = 22) | 12.09 (3.95) | 9.95 (3.77) | −19.82 (7.34) | 0.080 |